跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,166 条关于
“NeOnc Technologies Holdings”
全部
6,166
临床试验
656
药物
233
机构
445
资讯
4,832
去年
NeOnc Technologies Secures $50 Million Investment to Expand Brain Cancer Clinical Trials in MENA Region
去年
NeOnc Technologies Receives FDA Authorization for Phase II Brain Cancer Trial of NEO212
去年
NeOnc Technologies to List on Nasdaq Global Market with Novel Blood-Brain Barrier Therapeutics
11个月前
NeOnc Technologies Strengthens Scientific Advisory Board with Two Leading Duke Neuro-Oncologists
去年
FDA Grants Rare Pediatric Disease Designation to NEO100 for Aggressive Childhood Brain Cancer
去年
NeOnc Technologies Strengthens Competitive Edge with 176-Patent Global Portfolio
7个月前
NeOnc Technologies Secures $16 Million PIPE Investment to Advance CNS Cancer Therapies
6个月前
NeOnc Technologies to Present Phase 1 NEO212-01 Dose-Escalation Results for CNS Cancer Treatment
去年
NeOnc Technologies Partners with CBCC Global Research to Accelerate Brain Cancer Clinical Trials in India
3个月前
NeOnc Technologies Secures UAE IND Approval for NEO212, Advancing Oral Brain Cancer Therapy Toward Global Phase 2 Development
第 1 页，共 484 页
上一页
下一页
